Effects of CO2 and liquid digestate concentrations on the growth performance and biomass composition of Tetradesmus obliquus and Chlorella vulgaris microalgal strains.
IF 4.3 3区 工程技术Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Ángela Sánchez-Quintero, Aurélien Parsy, Amandine Adrien, Lea Spitzer, Javier Jiménez-Lamana, Susana C M Fernandes, Jean-Baptiste Beigbeder
{"title":"Effects of CO<sub>2</sub> and liquid digestate concentrations on the growth performance and biomass composition of <i>Tetradesmus obliquus</i> and <i>Chlorella vulgaris</i> microalgal strains.","authors":"Ángela Sánchez-Quintero, Aurélien Parsy, Amandine Adrien, Lea Spitzer, Javier Jiménez-Lamana, Susana C M Fernandes, Jean-Baptiste Beigbeder","doi":"10.3389/fbioe.2024.1459756","DOIUrl":null,"url":null,"abstract":"<p><p>This study evaluated the growth performance of <i>Tetradesmus obliquus</i> and <i>Chlorella vulgaris</i> microalgae cultivated in diluted liquid digestate supplemented with CO<sub>2</sub>, comparing their efficiency to that of a conventional synthetic media. The presence of an initial concentration of ammonium of 125 mg N-NH<sub>4</sub> <sup>+</sup>.L<sup>-1</sup> combined with the continuous injection of 1% v/v CO<sub>2</sub> enhanced the optimal growth responses and bioremediation potential for both strains in 200-mL cultures. In 6-L flat panel reactors, <i>T. obliquus</i> exhibited superior biomass production, achieving a final biomass concentration of 1.29 ± 0.06 g.L<sup>-1</sup>, while <i>C. vulgaris</i> reached only 0.36 ± 0.02 g.L<sup>-1</sup>. Both strains effectively contributed to the bioremediation of the digestate-based culture media, with up to 100% of N-NH<sub>4</sub> <sup>+</sup>, 50% of COD, and 55% of P-PO<sub>4</sub> <sup>3-</sup> removals. The high nitrogen levels in the digestate-based medium significantly increased protein content, with 46.21% ± 3.98% dry weight (DW) for <i>T. obliquus</i> and 44.17% ± 2.24% DW for <i>C. vulgaris</i> as compared to the microalgae cultivated in commercial media. Additionally, the metal content of the microalgal biomass was analyzed to assess its potential use as biostimulants in compliance with European regulations. While chromium concentrations slightly exceeded regulatory thresholds in both strains, the levels of other metals remained within permissible limits.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"12 ","pages":"1459756"},"PeriodicalIF":4.3000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755043/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2024.1459756","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study evaluated the growth performance of Tetradesmus obliquus and Chlorella vulgaris microalgae cultivated in diluted liquid digestate supplemented with CO2, comparing their efficiency to that of a conventional synthetic media. The presence of an initial concentration of ammonium of 125 mg N-NH4+.L-1 combined with the continuous injection of 1% v/v CO2 enhanced the optimal growth responses and bioremediation potential for both strains in 200-mL cultures. In 6-L flat panel reactors, T. obliquus exhibited superior biomass production, achieving a final biomass concentration of 1.29 ± 0.06 g.L-1, while C. vulgaris reached only 0.36 ± 0.02 g.L-1. Both strains effectively contributed to the bioremediation of the digestate-based culture media, with up to 100% of N-NH4+, 50% of COD, and 55% of P-PO43- removals. The high nitrogen levels in the digestate-based medium significantly increased protein content, with 46.21% ± 3.98% dry weight (DW) for T. obliquus and 44.17% ± 2.24% DW for C. vulgaris as compared to the microalgae cultivated in commercial media. Additionally, the metal content of the microalgal biomass was analyzed to assess its potential use as biostimulants in compliance with European regulations. While chromium concentrations slightly exceeded regulatory thresholds in both strains, the levels of other metals remained within permissible limits.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.